| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3336 | |||||||||||||||||||||||
| Submitter : | Mrs. Joyceanna Filone | Date & Time: | 12/15/2006 08:12:42 | |||||||||||||||||||||
| Organization : | Mrs. Joyceanna Filone | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Only ethical stem cells, not from aborted babies, should be used in the developement of vaccines. Non-objectional cell lines can be utilized. It is imperative that everyone benefit from these vaccines without having to compromise their moral beliefs. | ||||||||||||||||||||||||